New Jersey A 3734: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2022-05-02)

State: New Jersey · Session: 220 · Bill: A 3734

Subjects: PHARMACEUTIC

Sponsors: Haider, Shama A.

View New Jersey A 3734 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.